Lab-Grown skin could transform burn care for children

NCT ID NCT03229564

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial is testing a lab-grown skin substitute called denovoSkin in children with deep burns. The engineered skin is made from the child's own cells and is compared to the standard treatment of using a split-thickness skin graft. The goal is to see if denovoSkin can cover burns more effectively and safely, potentially reducing the amount of healthy skin needed for grafting. The study involves 12 children under 12 years old who have deep partial or full-thickness burns requiring surgical coverage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an autologous bio-engineered dermo-epidermal skin substitute called denovoSkin (EHSG-KF)
What this could lead to
If successful, this could offer a more effective and safer way to cover deep burns in children, potentially reducing the need for multiple surgeries and improving healing outcomes.
What could go wrong
This is an early-stage trial with only 12 children, so results may not apply broadly. The engineered skin might not integrate as well as standard grafts, and there is a risk of infection or rejection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURNS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dipartimento di Chirurgia Pediatrica Ospedale dei bambini Vittorio Buzzi

    Milan, Italy

  • Rode Kruis Ziekenhuis

    Beverwijk, 1940, Netherlands

  • Unità di Chirurgia Plastica e Ustioni Ospedale Santobono

    Naples, Italy

  • University Children's Hospital Zurich

    Zurich, 8032, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.